SNY vs. ABT
Compare and contrast key facts about Sanofi (SNY) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNY or ABT.
Correlation
The correlation between SNY and ABT is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNY vs. ABT - Performance Comparison
Key characteristics
SNY:
-0.24
ABT:
-0.03
SNY:
-0.21
ABT:
0.09
SNY:
0.98
ABT:
1.01
SNY:
-0.25
ABT:
-0.02
SNY:
-0.58
ABT:
-0.06
SNY:
9.36%
ABT:
8.14%
SNY:
22.28%
ABT:
17.92%
SNY:
-46.65%
ABT:
-45.66%
SNY:
-15.65%
ABT:
-16.48%
Fundamentals
SNY:
$123.78B
ABT:
$192.70B
SNY:
$1.85
ABT:
$3.29
SNY:
26.69
ABT:
33.77
SNY:
0.87
ABT:
2.19
SNY:
$36.66B
ABT:
$30.98B
SNY:
$25.74B
ABT:
$17.29B
SNY:
$9.62B
ABT:
$7.89B
Returns By Period
In the year-to-date period, SNY achieves a 2.36% return, which is significantly higher than ABT's -1.26% return. Over the past 10 years, SNY has underperformed ABT with an annualized return of 4.19%, while ABT has yielded a comparatively higher 11.72% annualized return.
SNY
2.36%
7.58%
-1.67%
-4.25%
2.30%
4.19%
ABT
-1.26%
-0.83%
7.20%
-0.34%
6.42%
11.72%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNY vs. ABT — Risk-Adjusted Performance Rank
SNY
ABT
SNY vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNY vs. ABT - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 4.13%, more than ABT's 2.02% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNY Sanofi | 4.13% | 4.22% | 3.83% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.79% | 4.19% |
ABT Abbott Laboratories | 2.02% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
SNY vs. ABT - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.65%, roughly equal to the maximum ABT drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for SNY and ABT. For additional features, visit the drawdowns tool.
Volatility
SNY vs. ABT - Volatility Comparison
Sanofi (SNY) has a higher volatility of 9.06% compared to Abbott Laboratories (ABT) at 4.04%. This indicates that SNY's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNY vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities